Kane SAC Limited (Series 2014-2)
The Artemis Catastrophe Bond and Insurance-linked Securities Deal Directory aims to provide a one-stop resource for information on every cat bond and ILS transaction we hold information on. The content of this Deal Directory is provided as is and there will be some omissions. Help us to keep these cat bond and ILS transaction summaries up to date by contacting us if you see an error or omission that you can correct.
Kane SAC Limited (Series 2014-2) - At a glance:
- Issuer / SPV: Kane SAC Limited (Series 2014-2)
- Cedent / Sponsor: Unknown
- Placement / structuring agent/s: ?
- Risk modelling / calculation agents etc: ?
- Risks / Perils covered: U.S. hurricane
- Size: $7.32m
- Trigger type: Indemnity
- Ratings: NR
- Date of issue: Jul 2014
Kane SAC Limited (Series 2014-2) - Full details
Global independent insurance management firm Kane has completed another private catastrophe bond issuance through its Kane SAC Limited Note Program, with a $7.32m Series 2014-2 renewal of the Series 2013-1 transaction issued a year ago.
This is the third privately placed and issued cat bond lite type deal to come out of the Kane SAC (Segregated Accounts Company) Program on the insurance managers platform and we’re told it renews the first deal on the platform, albeit at a slightly smaller size than the $9,523,770 2013-1 issue.
The $7.32m of private cat bond notes issued in the Kane SAC Series 2014-2 deal have been listed on the Bermuda Stock Exchange, with Appleby Securities (Bermuda) acting as listing sponsor.
The 2014-2 notes were admitted to listing on the 10th July, according to the BSX announcement, and have a due date of the 10th June 2015, so having around an 11 month term, much like the 2013-1 deal which matured recently and that this transaction renews.
Kane told Artemis that the deal covers U.S. hurricane risks and uses an indemnity trigger.
The Artemis Catastrophe Bond & Insurance-Linked Securities Deal Directory is copyright © Steve Evans Ltd. Reproduction or publication without permission is not permitted. Use of this information within a commercial product, or for profit, without a license is strictly prohibited. Contact us if you would like to use this content or to discuss licensing.